XML 49 R38.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2022
Share-based Payment Arrangement [Abstract]  
Summary Of Stock-Based Compensation Expense
Stock-based compensation expense is recognized in cost of revenues, corporate, technology and production systems, and selling, general, and administrative expense in the accompanying unaudited condensed consolidated statements of operations and comprehensive (loss) income as follows:
 Three Months Ended
September 30,
Nine Months Ended
September 30,
 2021202220212022
(in thousands)
Stock-based compensation expense    
Cost of revenues$937 $384 $958 $1,208 
Corporate technology and production systems1,4497741,4871,803
Selling, general and administrative23,1965,13524,79114,413
Total stock-based compensation expense$25,582 $6,293 $27,236 $17,424 
Share-based Payment Arrangement, Option, Activity
The table below provides a summary of service-based vesting options (“SVOs”) and performance-based stock options (“PSOs”) currently outstanding under the 2015 Plan for the nine months ended September 30, 2022:
Outstanding SVOsOutstanding PSOs
Number of
Shares
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Life
(years)
Aggregate
Intrinsic
Value
Number of
Shares
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Life
(years)
Aggregate
Intrinsic
Value
(in thousands, except shares and per share amounts)
Balances as of December 31, 20216,450,978 $9.58 6.70$70,510 3,096,830 $10.05 7.04$32,394 
Exercised(229,260)9.37 2,902 (14,975)9.68 157 
Balances as of September 30, 2022 (1)
6,221,718 $9.59 5.43$50,100 3,081,855 $10.05 3.70$23,387 
__________
(1)    All SVOs and PSOs are exercisable as of September 30, 2022.
The table below provides a summary of stock option activity under the 2021 Equity Plan for the nine months ended September 30, 2022:

Weighted Average Exercise PriceWeighted Average Contractual Term (in years)Aggregate Intrinsic ValueWeighted Average Fair Value
(per share)
Number of Shares
(in thousands, except share and per share amounts)
Outstanding at December 31, 20213,918,454 $23.00 9.65$— 
Granted622,919 22.35 $10.43 
Forfeited / Cancelled(95,254)23.00 
Outstanding at September 30, 2022
4,446,119 $22.91 8.98$— 
Share-based Payment Arrangement, Restricted Stock Activity
The table below provides a summary of restricted stock activity under the 2021 Equity Plan for the nine months ended September 30, 2022:
Weighted Average Fair Value
(per share)
Number of Shares
Unvested at December 31, 20211,779,716 $23.01 
Granted886,018 21.40 
Forfeited / Cancelled(333,690)22.86 
Vested(5,914)22.83 
Unvested at September 30, 2022
2,326,130 $22.42 
The table below provides a summary of restricted stock unit activity under the 2021 Equity Plan for the nine months ended September 30, 2022:
Number of SharesWeighted Average Fair Value
(per share)
Unvested at December 31, 202141,933 $23.00 
Granted11,368 21.91 
Forfeited / Cancelled(4,632)23.00 
Unvested at September 30, 2022
48,669 $22.74